Abstract

AIM: to reduce antibiotic resistance of infectious agents in colorectal surgery using optimal antibiotic therapy. PATIENTS AND METHODS: single-center interventional study with retrospective control has been done. Start point of intervention was January 2017, when it was provided direct administrative control of perioperative antibiotic prophylaxis protocols and empirical antibiotic therapy. The study included 200 patients after colorectal surgery in 2016-2017. Patients divided in two groups: in 2016 y – control (A), in 2017 – interventional one (B). RESULTS: significant decrease was detected in total antibiotic use from 16.1 to 12.2 defined daily dose (DDD) and in duration of antibiotic prophylaxis from 5.5 to 1.9 days (p<0.001). Incidence of infection caused by multi-resistant strains reduced from 84.3% to 50% (p<0.001). Analysis of etiology septic complications in colorectal patients showed a decrease in the number of Enterobacteriales, producing extended-spectrum beta-lactamases (ESBL) from 33.3% to 11.8% (р<0.01). The incidence of carbapenem-resistant Klostridium pneumoniae reduced from 7.8% до 0%, р=0.031. ESKAPE group pathogens decreased from 24 (47.1%) to 12 (17.7%), р<0.001. No difference in postoperative infectious morbidity between groups was detected (32.9% vs 31.0%, р=0.88). Incidence of antibiotic-associated diarrhea decreased from 5% to 0% (р=0.03). CONCLUSION: direct control of antibiotic prophylaxis protocols and empirical antibiotic therapy allowed to decrease the rate of antibiotic use and to decrease rate of infection complications caused by antibiotic resistance strains.

Highlights

  • RESULTS: significant decrease was detected in total antibiotic use from 16.1 to 12.2 defined daily dose (DDD) and in duration of antibiotic prophylaxis from 5.5 to 1.9 days (p

  • Analysis of etiology septic complications in colorectal patients showed a decrease in the number of Enterobacteriales, producing extended-spectrum beta-lactamases (ESBL) from 33.3% to 11.8% (р

  • CONCLUSION: direct control of antibiotic prophylaxis protocols and empirical antibiotic therapy allowed to decrease the rate of antibiotic use and to decrease rate of infection complications caused by antibiotic resistance strains

Read more

Summary

КОЛОПРОКТОЛОГИИ В УСЛОВИЯХ РАСТУЩЕЙ АНТИБИОТИКОРЕЗИСТЕНТНОСТИ

Стойко Ю.М., Гусаров В.Г., Колозян Д.А., Левчук А.Л., Максименков А.В. Снизить долю антибиотикорезистентных (АБР) штаммов возбудителей инфекционных осложнений в хирургической колопроктологии путем оптимизации использования антимикробных препаратов (АМП). Начало интервенции – январь 2017 г., когда был введен строгий контроль соблюдения протоколов антибиотикопрофилактики (АБП) и эмпирической антимикробной терапии (АМТ). В исследование включены 200 больных, оперированных на толстой и прямой кишке в 2016-2017 г. При анализе этиологии гнойно-септических осложнений (ГСО) у хирургических больных колопроктологического профиля отмечено значимое снижение числа штаммов порядка Enterobacteriales, продуцирующих бета-лактамазы расширенного спектра (БЛРС) с 33,3% до 11,8% (р

ANTIMICROBIAL RESISTANCE BACKGROUND
ПАЦИЕНТЫ И МЕТОДЫ
Кишечные стомы
Findings
Число больных с осложнениями Летальность
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.